SCHEMBL5007650

SCHEMBL5007650

CCc1nc(N)c2cn[nH]c2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 2/20 0.47
RET P07949 1/20 0.47
PI4KA P42356 1/20 0.47
LRRK2 Q5S007 1/20 0.47
PI4K2B Q8TCG2 1/20 0.47
PI4K2A Q9BTU6 1/20 0.47
PI4KB Q9UBF8 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 3/20 0.38
HTT P42858 1/20 0.38
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
PDPK1 O15530 1/20 0.36
CHEK1 O14757 1/20 0.35
AURKA O14965 1/20 0.35
CDK2 P24941 1/20 0.35
HTR2A P28223 3/20 0.34
HTR2C P28335 3/20 0.34
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7540624 0.83 XDH (0.42) XDHRETPI4KALRRK2PI4K2B
SCHEMBL3258117 0.82 XDH (0.41) XDHRETPI4KALRRK2PI4K2B
SCHEMBL14985864 0.80 HTT (0.42) XDHSMN1; SMN2ALDH1A1HTTADORA2A
SCHEMBL12113770 0.80 SMN1; SMN2 (0.41) XDHSMN1; SMN2ALDH1A1HTTADORA2A
SCHEMBL3254950 0.77 CYP1A2 (0.44) XDHRETPI4KALRRK2PI4K2B
SCHEMBL1981095 0.76 RET (0.52) XDHRETPI4KALRRK2PI4K2B
SCHEMBL29487078 0.75 XDH (0.55) XDHRETPI4KALRRK2PI4K2B
SCHEMBL1014920 0.75 XDH (0.55) XDHRETPI4KALRRK2PI4K2B
SCHEMBL31252574 0.75 RET (0.47) XDHRETPI4KALRRK2PI4K2B
SCHEMBL13829328 0.73 HTR2C (0.51) XDHRETPI4KALRRK2PI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080292561-A1 Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents GLAXO GROUP LIMITED 2008-11-27 US disclosed
US-20080292561-A1 Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents GLAXO GROUP LIMITED 2008-11-27 US disclosed
US-20080292561-A1 Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents GLAXO GROUP LIMITED 2008-11-27 US disclosed
WO-2007054294-A1 PYRAZOLO-PYRIMIDINE DERIVATIVES AS ANTI-INFLAMMATORY AGENTS GLAXO GROUP LIMITED (GB) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080292561-A1 Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents NOD1, FPR3, FPR1 XDH 333/4885RET 4211/4885PI4KA 2482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.